Mushrooms, pregnancy, diabetes, suburbs: Morning Rounds

The latest news in the health and medicine world is full of interesting developments and findings. Let’s dive into the top stories making headlines today.

Magic mushrooms decision suggests possible discord within Trump administration

In a surprising turn of events, the Trump administration vetoed a psilocybin treatment from Compass Pathways that was set to receive a speedy regulatory review. This decision has raised questions about possible discord within the administration, with some officials having conservative views on drugs. Advocates for psychedelic medicine are facing challenges in trying to navigate these differing viewpoints within the administration. To learn more about why Compass lost the voucher and the current state of psychedelic medicine under the Trump administration, check out the detailed report by STAT reporters.

Plastic surgeons take a stance on gender-affirming procedures

The American Society of Plastic Surgeons recently released new recommendations regarding gender-affirming surgeries for transgender and nonbinary patients. The recommendations advise that these surgeries be delayed until the patient is at least 19 years old, marking a departure from previous guidelines. With over 23,000 individuals aged 19 and under undergoing plastic surgery in 2024, these new guidelines aim to provide ethical considerations for surgeries performed on both cisgender and transgender adolescents. Learn more about the rationale behind these recommendations and the response from the Trump administration in the full report by STAT’s Daniel Payne.

How diabetes in pregnancy may be linked to epilepsy in babies

A recent Canadian study has found a potential link between diabetes during pregnancy and the risk of children developing epilepsy. Whether it’s pre-gestational, type 1, or type 2 diabetes, the study suggests that all forms of diabetes increase the likelihood of children developing epilepsy. The study underscores the importance of monitoring children exposed to diabetes in utero for signs of epilepsy early on. With rates of type 2 diabetes on the rise, this finding has significant implications for maternal health and child development. Dive into the details of this groundbreaking study published in Pediatrics to understand the potential connection between diabetes and epilepsy.

In research areas, what’s too close for comfort?

For graduate students and postdoctoral researchers in academia, the decision to stay close to a former adviser’s research area or branch out independently can be a challenging one. A new study suggests that some overlap with a mentor’s research can be beneficial for young life scientists, but there is a fine line between collaboration and independence. Understanding how to navigate this balance is crucial for the career development of aspiring researchers. Get insights from the study’s corresponding author on how to signal independence and creativity while still maintaining connections to your mentor’s work.

The suburbs are a quintessential American construct, as in many ways is our uniquely prohibitive methadone treatment system

A recent commentary published in JAMA Network Open sheds light on the challenges faced by individuals seeking methadone treatment for opioid addiction, particularly in suburban areas. The study highlights disparities in access to methadone treatment programs, especially for communities with high overdose death rates. As the opioid crisis continues to impact communities across the country, addressing barriers to treatment access is crucial for improving outcomes for individuals struggling with addiction. Explore the editorial accompanying the study for a deeper understanding of the obstacles faced by patients seeking methadone treatment.

A drug for restless leg syndrome wrecked his life

Aaron Sanders shares his harrowing experience with a drug prescribed for restless leg syndrome in a poignant First Opinion essay. Despite finding relief from his symptoms, the drug’s unexpected side effects took a toll on Sanders’s life, leading to profound personal consequences. Sanders’s story serves as a cautionary tale about the potential risks associated with long-term medication use and underscores the importance of monitoring for adverse effects. Discover the full extent of Sanders’s journey and the impact of the drug on his life in this compelling narrative.

What we’re reading

• Long COVID affects millions of children. The largest pediatric trial so far launches this year, The 19th
• FDA Commissioner Marty Makary tries to soothe staff concerns over voucher program, STAT
• NIH grant disruptions slow down breast cancer research, KFF Health News
• Novo Nordisk sees lower sales, profits as Wegovy faces growing competition, STAT

  Stay informed with the latest updates in health and medicine by exploring these insightful reads on critical issues facing the industry. Whether it’s advancements in research, policy changes, or personal narratives, these stories offer valuable insights into the ever-evolving landscape of healthcare.